CEACAM6 and serous adenocarcinoma: In ovarian cancers, CEACAM6 expression was highest in mucinous carcinoma (seven out of eight samples, 88 %) (Fig. 5e), whereas only 17 % of serous carcinoma samples were positive for CEACAM6.